BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 34868054)

  • 1. Immunomodulation in the Treatment of Periodontitis: Progress and Perspectives.
    Yang B; Pang X; Li Z; Chen Z; Wang Y
    Front Immunol; 2021; 12():781378. PubMed ID: 34868054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future prospects of systemic host modulatory agents in periodontal therapy.
    Gokhale SR; Padhye AM
    Br Dent J; 2013 May; 214(9):467-71. PubMed ID: 23660908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory Role of Stem Cells from Human Exfoliated Deciduous Teeth on Periodontal Regeneration.
    Gao X; Shen Z; Guan M; Huang Q; Chen L; Qin W; Ge X; Chen H; Xiao Y; Lin Z
    Tissue Eng Part A; 2018 Sep; 24(17-18):1341-1353. PubMed ID: 29652608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The colorectal cancer immune microenvironment and approach to immunotherapies.
    Koi M; Carethers JM
    Future Oncol; 2017 Aug; 13(18):1633-1647. PubMed ID: 28829193
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances of exosomes in periodontitis treatment.
    Lin H; Chen H; Zhao X; Ding T; Wang Y; Chen Z; Tian Y; Zhang P; Shen Y
    J Transl Med; 2022 Jun; 20(1):279. PubMed ID: 35729576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review.
    Reddy MS; Geurs NC; Gunsolley JC
    Ann Periodontol; 2003 Dec; 8(1):12-37. PubMed ID: 14971246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory effects of current cancer treatment and the consequences for follow-up immunotherapeutics.
    Mooradian MJ; Sullivan RJ
    Future Oncol; 2017 Aug; 13(18):1649-1663. PubMed ID: 28776423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial flagellin-a potent immunomodulatory agent.
    Hajam IA; Dar PA; Shahnawaz I; Jaume JC; Lee JH
    Exp Mol Med; 2017 Sep; 49(9):e373. PubMed ID: 28860663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory and potential therapeutic role of mesenchymal stem cells in periodontitis.
    Racz GZ; Kadar K; Foldes A; Kallo K; Perczel-Kovach K; Keremi B; Nagy A; Varga G
    J Physiol Pharmacol; 2014 Jun; 65(3):327-39. PubMed ID: 24930504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of biomaterials in periodontal tissue repair and reconstruction in the presence of inflammation under periodontitis through the foreign body response: Recent progress and perspectives.
    Chu C; Zhao X; Rung S; Xiao W; Liu L; Qu Y; Man Y
    J Biomed Mater Res B Appl Biomater; 2022 Jan; 110(1):7-17. PubMed ID: 34142745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases.
    Bunte K; Beikler T
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humanized Mouse Models for the Study of Periodontitis: An Opportunity to Elucidate Unresolved Aspects of Its Immunopathogenesis and Analyze New Immunotherapeutic Strategies.
    Rojas C; García MP; Polanco AF; González-Osuna L; Sierra-Cristancho A; Melgar-Rodríguez S; Cafferata EA; Vernal R
    Front Immunol; 2021; 12():663328. PubMed ID: 34220811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental periodontitis in mice selected for maximal or minimal inflammatory reactions: increased inflammatory immune responsiveness drives increased alveolar bone loss without enhancing the control of periodontal infection.
    Trombone AP; Ferreira SB; Raimundo FM; de Moura KC; Avila-Campos MJ; Silva JS; Campanelli AP; De Franco M; Garlet GP
    J Periodontal Res; 2009 Aug; 44(4):443-51. PubMed ID: 18973535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory and immune pathways in the pathogenesis of periodontal disease.
    Cekici A; Kantarci A; Hasturk H; Van Dyke TE
    Periodontol 2000; 2014 Feb; 64(1):57-80. PubMed ID: 24320956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host-Microbial Interactions in Systemic Lupus Erythematosus and Periodontitis.
    Pessoa L; Aleti G; Choudhury S; Nguyen D; Yaskell T; Zhang Y; Li W; Nelson KE; Neto LLS; Sant'Ana ACP; Freire M
    Front Immunol; 2019; 10():2602. PubMed ID: 31781106
    [No Abstract]   [Full Text] [Related]  

  • 16. Challenges and Tissue Engineering Strategies of Periodontal-Guided Tissue Regeneration.
    Liu Y; Guo L; Li X; Liu S; Du J; Xu J; Hu J; Liu Y
    Tissue Eng Part C Methods; 2022 Aug; 28(8):405-419. PubMed ID: 35838120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory Immune Cells in Idiopathic Pulmonary Fibrosis: Friends or Foes?
    van Geffen C; Deißler A; Quante M; Renz H; Hartl D; Kolahian S
    Front Immunol; 2021; 12():663203. PubMed ID: 33995390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of immunotherapy for gastrointestinal stromal tumor.
    Tan Y; Trent JC; Wilky BA; Kerr DA; Rosenberg AE
    Cancer Gene Ther; 2017 Mar; 24(3):130-133. PubMed ID: 28186088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response.
    Hajishengallis G
    Trends Immunol; 2014 Jan; 35(1):3-11. PubMed ID: 24269668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological Mechanisms Underneath the Efficacy of Cancer Therapy.
    Galluzzi L; Zitvogel L; Kroemer G
    Cancer Immunol Res; 2016 Nov; 4(11):895-902. PubMed ID: 27803050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.